DR. CALLANT EWOUT
ActiveDR. CALLANT EWOUT has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €468k and a net result of €170k. Equity is growing by ~52.7% per year across the filed fiscal years. Its solvency ranks better than 65% of 16426 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
97
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+1
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45k at 30 days acceptable
Liquidity ample (current ratio 4.42 against 4.12 in 2024; short-term debt: 17.8% and cash: 46.6% of total assets), and 23% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
77%
Return on assets
28%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
126 d early
2024
23 d early
2023
6 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
18-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€468k▲ 57.1%
2024 · €298k
2023: €154k
2024: €298k
2023 → 2025
Total assets
€608k▲ 50.5%
2024 · €404k
2023: €206k
2024: €404k
2023 → 2025
Net result
€170k▲ 18.4%
2024 · €144k
2023: €149k
2024: €144k
2023 → 2025
Working capital
€370k▲ 86.5%
2024 · €198k
2023: €155k
2024: €198k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€154k-€298k▲ 93.2%€468k▲ 57.1%
Operating result€193k-€188k▼ 2.8%€219k▲ 16.5%
Net result€149k-€144k▼ 3.7%€170k▲ 18.4%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 17% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €608k
Fixed assets
€130k▼ 8.6%
Current assets
€478k▲ 82.4%
Equity and liabilities €608k
Equity
€468k▲ 57.1%
Debt
€140k▲ 31.9%
The debt ratio falls from 26.2% to 23.0%. Equity and debt are higher.
Key figures and ratios
EBITDA
€232k▲
2024 · €207k
Cash flow
€184k▲
2024 · €163k
Solvency
77.0%▲
2024 · 73.8%
Current ratio
4.42▲
2024 · 4.12
Quick ratio
4.42▲
2024 · 4.12
Debt / equity
0.30▼
2024 · 0.36
ROE
36.3%▼
2024 · 48.2%
ROA
28.0%▼
2024 · 35.6%
Interest coverage
169.55▲
2024 · 107.98
Debt
€140k▲
2024 · €106k
Debt ≤ 1 year
€108k▲
2024 · €64k
Debt > 1 year
€24k▼
2024 · €35k
Income taxes
€51k▲
2024 · €43k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€404k€608k▲
Fixed assets21/28€142k€130k▼
Tangible fixed assets22/27€117k€105k▼
Plant, machinery and equipment23€2k€3k▲
Furniture and vehicles24€4k€3k▼
Leasing and similar rights25€46k€35k▼
Other tangible fixed assets26€64k€64k=
Financial fixed assets28€25k€25k=
Current assets29/58€262k€478k▲
Amounts receivable after more than one year29€80k€135k▲
Other amounts receivable291€80k€135k▲
Amounts receivable within one year40/41€21k€29k▲
Other amounts receivable41€21k€29k▲
Cash at bank and in hand54/58€139k€283k▲
Deferred charges and accrued income490/1€22k€31k▲
Equity and liabilities
Total equity and liabilities10/49€404k€608k▲
Equity10/15€298k€468k▲
Contributions10/11€5k€5k=
Reserves13€293k€463k▲
Distributable reserves133€293k€463k▲
Amounts payable17/49€106k€140k▲
Amounts payable after more than one year17€35k€24k▼
Financial debts170/4€35k€24k▼
Amounts payable within one year42/48€64k€108k▲
Current portion of amounts payable after more than one year42€11k€11k▲
Trade debts44€2k€1k▼
Suppliers440/4€2k€1k▼
Taxes, remuneration and social security45€43k€94k▲
Taxes450/3€43k€94k▲
Other amounts payable47/48€8k€2k▼
Accrued charges and deferred income492/3€7k€8k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€19k€13k▼
Other operating charges640/8€366€741▲
Gross operating margin9900€207k€233k▲
Operating profit (loss)9901€188k€219k▲
Financial income75/76B€605€4k▲
Recurring financial income75€605€4k▲
Financial charges65/66B€2k€1k▼
Recurring financial charges65€2k€1k▼
Profit (loss) for the period before taxes9903€187k€222k▲
Income taxes67/77€43k€51k▲
Profit (loss) for the period9904€144k€170k▲
Profit (loss) for the period to be appropriated9905€144k€170k▲
Appropriation of the result
Profit (loss) to be appropriated9906€144k€170k▲
Transfer to equity691/2€144k€170k▲
To other reserves6921€144k€170k▲
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €170k ▲18.4%
Operating result €219k, net result €170k, both a record.
08-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Weakest financial yearnet €144k ▼3.7%
Net result drops to €144k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €200kEq €298k ▲93.2%
2 profitable years in a row build equity to €298k.
06-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 6 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Guldenroedestraat 349030 GentGround area
1,598 m²
Building footprint
418 m²
Volume, LiDAR
2,003 m³
2 parcels, Flanders · tallest building 12.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. CALLANT EWOUT
since 20222.337.210.941
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44038A0471/00L002 | Flanders | 864 m² | 1 · 186 m² | 12.6 m · 1 fl. |
| 44017C1014/00N002 | Flanders | 734 m² | 1 · 232 m² | 6.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Cabinet Médical de la Haute Lesse
BE 0842.493.795
Tellin · Eq €468k
VIREMED
BE 0741.597.167
Dilsen-Stokkem · Eq €468k
Centre de Médecine Héraclès
BE 0848.400.503
Binche · Eq €468k
Dr. L. JANSSEN
BE 0545.971.032
Lummen · Eq €468k
DR. BIRGIT WIJGAERTS, ALGEMENE GENEESKUNDE
BE 0887.023.131
Lummen · Eq €468k
Of 9,119 companies in sector 86210 we hold annual accounts for 6,336. 4,945 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded03-10-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 18-09-2026. Scores and ratios are computed by Checked and are not a credit decision.